Pay in 4 interest-free payments of $6.09 Learn more
Ships within 48 hours · Estimated delivery Oct 12 - Oct 17
Fewer patients had impaired glucose tolerance and saw their cholesterol profiles improve Trial #6 was the nail in the coffin: The group taking AOD-9604 and the group taking the placebo were also following a strict diet and exercise routine over the entire 24-week period yet the weight loss induced in the AOD-9604 group was not statistically significant (at least not compared to HGH)
A faster metabolism may lead to quicker absorption and utilization, potentially speeding up the onset of benefits
Vision disturbances
When you administer 5-Amino-1MQ via injection, you bypass the digestive system's gauntlet entirely
In one notable study, patients who received Vitamin B12 supplements, especially when combined with folic acid and sun exposure, showed re-pigmentation in affected areas
Key Takeaways AOD 9604 produces 2-3 times greater fat loss than placebo in clinical trials with women Standard dosing ranges from 0.5mg to 1mg daily via subcutaneous injection Side effects occur in fewer than 5% of women, primarily mild injection site reactions Results typically become visible after 4-6 weeks of consistent daily administration The peptide preserves lean muscle mass while specifically targeting fat tissue How AOD 9604 Works for Female Fat Loss AOD 9604 functions by activating beta-3 adrenergic receptors in adipose tissue, specifically triggering lipolysis without the growth-promoting effects of full-length growth hormone
